VivoSim Labs (VIVS) Current Leases (2012 - 2026)
VivoSim Labs (VIVS) posted quarterly Current Leases of $447000.0 for Q1 2026, down 14.2% year-over-year from $521000.0 in Q1 2025, and down 16.14% quarter-over-quarter from $533000.0 in Q4 2025.
VivoSim Labs (VIVS) Current Leases (2012 - 2026) Analysis & Trends
VivoSim Labs' Current Leases history runs 11 years deep, the most recent figure standing at $447000.0 for Q1 2026.
- In Q1 2026, Current Leases fell 14.2% year-over-year to $447000.0; the TTM figure through Mar 2026 stood at $447000.0 (down 14.2% YoY), while the FY2026 annual figure was $447000.0, down 14.2% from the prior year.
- Current Leases for Q1 2026 stood at $447000.0, down from $533000.0 in the prior quarter.
- The five-year high for Current Leases was $533000.0 in Q4 2025, with the low at $447000.0 in Q1 2026.
- The 5-year median for Current Leases is $502000.0 (2023), against an average of $501294.1.
- The sharpest annual moves came in 2025 and 2026: Current Leases grew 3.09% in 2025, then fell 14.2% in 2026.
- VivoSim Labs' Current Leases stood at $488000.0 in 2022, then grew by 2.87% to $502000.0 in 2023, then climbed by 2.99% to $517000.0 in 2024, then rose by 3.09% to $533000.0 in 2025, then dropped by 16.14% to $447000.0 in 2026.
- Business Quant data shows VIVS's Current Leases at $447000.0 in Q1 2026, $533000.0 in Q4 2025, and $528000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | - |
| 10 | VivoSim Labs | 1.46 Mn | 1.46 Mn | - | 316,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 316,000.00 |
| Mar 31, 2026 | 447,000.00 |
| Dec 31, 2025 | 533,000.00 |
| Sep 30, 2025 | 528,000.00 |
| Jun 30, 2025 | 524,000.00 |
| Mar 31, 2025 | 521,000.00 |
| Dec 31, 2024 | 517,000.00 |
| Sep 30, 2024 | 513,000.00 |
| Jun 30, 2024 | 510,000.00 |
| Mar 31, 2024 | 506,000.00 |
| Dec 31, 2023 | 502,000.00 |
| Sep 30, 2023 | 499,000.00 |
| Jun 30, 2023 | 495,000.00 |
| Mar 31, 2023 | 492,000.00 |
| Dec 31, 2022 | 488,000.00 |
| Sep 30, 2022 | 486,000.00 |
| Jun 30, 2022 | 482,000.00 |
| Mar 31, 2022 | 479,000.00 |
| Dec 31, 2021 | 475,000.00 |
| Sep 30, 2019 | 1.04 Mn |